Author(s): Pleasure SJ, Lee VM
We have identified a human cell line with a phenotype resembling committed CNS neuronal precursor cells. NTera 2/cl.D1 (NT2/D1) cells expressed nestin and vimentin, intermediate filament (IF) proteins expressed in neuroepithelial precursor cells, as well as MAP1b, a microtubule-associated protein (MAP) expressed in human neuroepithelium. NT2/D1 cells also expressed the cell adhesion molecules NCAM and N-cadherin which are thought to be important in cellcell interactions within the neuroepithelium. These NT2/D1 cells also expressed small amounts of NF-L, α-internexin, NF-M, and MAP2c, indicating that they are committed to a neuronal fate. Previous studies have shown that, following RA treatment, a proportion of NT2/D1 cells terminally differentiate into neurons and that this occurs via an asymmetric stem cell mode of differentiation. In light of the identification of the neuroepithelial phenotype of NT2/D1 cells we decided to examine more closely the relationship of in vitro neurogenesis in NT2/D1 cells, during RA treatment to that of neurons in vivo. Three days after RA treatment, islands of NT2/D1 cells showed increased expression of neurofilament proteins and increased phosphorylation of NF-M. By 10–14 days, these cells began to resemble neurons morphologically, i.e., with rounded cell bodies and processes. These neuronal cells were clustered into clumps which rested on top of a layer of progenitor cells. In this upper layer, the neurons began to express MAP2b and tau and extinguished their expression of mestin. Recently, we developed a method for obtaining pure cultures of neurons from RA treated NT2/D1 cells. The phenotype of these postmitotic neurons is clearly dissociated from that of the untreated NT2/D1 cells. Given the data obtained in this study and the characterization of the neurons derived from NT2/D1 cells, we propose that NT2/D1 cells are a committed human neuronal precursor cell line which retains some stem cell characteristics and is capable only of terminal differentiation into neurons.
Referred From: https://onlinelibrary.wiley.com/doi/10.1002/jnr.490350603
Author(s): Colborn T
Author(s): Herbert MR
Author(s): Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, et al.
Author(s): Grandjean P, Landrigan PJ
Author(s): Grandjean P, Landrigan PJ
Author(s): Makris SL, Raffaele K, Allen S, Bowers WJ, Hasset U
Author(s): Middaugh LD, Dow-Edwards D, Li AA
Author(s): Cooper RL, Lamb JC, Barlow SM
Author(s): Doe JE, Boobis AR, Blacker A, Dellarco V, Doerrer NG, et al.
Author(s): Couillard-Despres S, Quehl E, Altendorfer K, Bentley K, Brady AM, et al.
Author(s): Hill EJ, Woehrling EK, Prince M, Coleman MD
Author(s): Hou Z, Zhang J, Schwartz MP, Stewart R, Page CD, et al.
Author(s): Laurenza I, Pallocca G, Mennecozzi M, Scelfo B, Pamies D, et al.
Author(s): Menzner AK, AbolpourMofrad S, Friedrich O, Gilbert DF
Author(s): Pallocca G, Fabbri M, Sacco MG, Gribaldo L, Pamies D, et al.
Author(s): Haile Y, Fu W, Shi B, Westaway D, Baker G, et al.
Author(s): Andrews PW
Author(s): Coyne L, Shan M, Przyborski SA, Hirakawa R, Halliwell RF
Author(s): Kuenzel K, Friedrich O, Gilbert DF
Author(s): Pleasure SJ, Page C, Lee VM
Author(s): Stewart R, Coyne L, Lako M, Halliwell RF, Przyborski SA
Author(s): Hsu TC, Liu KK, Chang HC, Hwang E, Chao JI
Author(s): Megiorni F, Mora B, Indovina P, Mazzilli MC
Author(s): Paquet-Durand F, Tan S, Bicker G
Author(s): Podrygajlo G, Tegenge MA, Gierse A
Author(s): Yao ZX, Han Z, Xu J, Greeson J, Lecanu L, et al.
Author(s): AbolpourMofrad S, Kuenzel K, Friedrich O, Gilbert DF